Prognostic Value of Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma.
作者信息
Consul Nikita
出版信息
Radiol Imaging Cancer. 2021 Sep;3(5):e219018. doi: 10.1148/rycan.2021219018.
Abstract
摘要
相似文献
1
Prognostic Value of Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma.钆塞酸增强磁共振成像特征对增殖性肝细胞癌的预后价值
Radiol Imaging Cancer. 2021 Sep;3(5):e219018. doi: 10.1148/rycan.2021219018.
2
Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma.钆塞酸增强 MRI 的动脉减影图像提高了早期肝细胞癌的诊断准确性。
J Hepatol. 2019 Sep;71(3):534-542. doi: 10.1016/j.jhep.2019.05.005. Epub 2019 May 18.
3
Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study.钆塞酸二钠增强磁共振成像特征的最佳组合在肝细胞癌无创性鉴别诊断中的应用：JAMP-HCC 研究。
Magn Reson Med Sci. 2021 Mar 1;20(1):47-59. doi: 10.2463/mrms.mp.2019-0193. Epub 2020 Feb 27.
4
Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI-RADS).钆塞酸二钠在慢性肝病患者中的应用及其对肝脏影像报告和数据系统（LI-RADS）的影响。
J Magn Reson Imaging. 2019 May;49(5):1236-1252. doi: 10.1002/jmri.26540. Epub 2019 Jan 4.
5
Evaluation of combined Gd-EOB-DTPA and gadobutrol magnetic resonance imaging for the prediction of hepatocellular carcinoma grading.钆塞酸二钠与钆布醇联合磁共振成像用于预测肝细胞癌分级的评估
Acta Radiol. 2016 Aug;57(8):932-8. doi: 10.1177/0284185115616293. Epub 2015 Nov 18.
6
Liver Imaging Reporting and Data System v2014 With Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging: Validation of LI-RADS Category 4 and 5 Criteria.《肝脏影像报告和数据系统（2014版）与钆塞酸二钠增强磁共振成像：LI-RADS 4类和5类标准的验证》
Invest Radiol. 2016 Aug;51(8):483-90. doi: 10.1097/RLI.0000000000000258.
7
Editorial Comment: An Algorithm to Distinguish Between Hepatocellular Adenoma Subtypes on Gadoxetate Disodium-Enhanced MRI.编者按：钆塞酸二钠增强磁共振成像鉴别肝细胞腺瘤亚型的算法
AJR Am J Roentgenol. 2023 Apr;220(4):549. doi: 10.2214/AJR.22.28613. Epub 2022 Oct 12.
8
LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.LI-RADS 版本 2017 与版本 2018：钆塞酸二钠增强 MRI 诊断肝细胞癌。
Radiology. 2019 Sep;292(3):655-663. doi: 10.1148/radiol.2019182867. Epub 2019 Jul 16.
9
Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting.钆塞酸二钠增强 MRI 在肝细胞癌管理中的诊断工具作用：2020 年亚太多学科专家会议报告。
Korean J Radiol. 2022 Jul;23(7):697-719. doi: 10.3348/kjr.2021.0593. Epub 2022 May 9.
10
Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent.钆塞酸二钠肝胆期与细胞外对比剂延迟期图像对肝细胞癌显示的比较。
Abdom Radiol (NY). 2016 Aug;41(8):1522-31. doi: 10.1007/s00261-016-0703-1.
本文引用的文献
1
Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.钆塞酸增强 MRI 特征对手术后增殖型肝细胞癌具有预后价值。
Radiology. 2021 Sep;300(3):572-582. doi: 10.1148/radiol.2021204352. Epub 2021 Jul 6.
Zotero 插件